<DOC>
	<DOCNO>NCT02295202</DOCNO>
	<brief_summary>Obstructive Sleep Apnea ( OSA ) common condition may induce hemodynamic metabolic dysregulation . However , clear OSA mere epiphenomenon contributes increase morbidity associate metabolic syndrome . This study design evaluate impact OSA treatment CPAP consecutive patient metabolic syndrome .</brief_summary>
	<brief_title>Impact Obstructive Sleep Apnea Treatment Patients With Metabolic Syndrome</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Apnea</mesh_term>
	<mesh_term>Sleep Apnea Syndromes</mesh_term>
	<mesh_term>Metabolic Syndrome X</mesh_term>
	<mesh_term>Sleep Apnea , Obstructive</mesh_term>
	<criteria>Metabolic Syndrome ( ATP III ) Moderate severe OSA Smokers Patients chronic use medication Neurological disease Coronary artery disease Acute heart failure Chronic renal failure ( GFR &lt; 30 ml/min ) Chronic obstructive pulmonary disease Mild OSA patient BMI 40 kg/m2 .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>